首页 > 最新文献

Vascular最新文献

英文 中文
Extracranial internal carotid artery aneurysm: Surgical approach to a rare entity. 颅外颈内动脉瘤:罕见病例的手术方法。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-12-01 Epub Date: 2024-10-13 DOI: 10.1177/17085381241290634
Didem Melis Oztas, Seckin Cobanoglu, Asli Cakir, Okan Kuguoglu, Emre Oteyaka, Murat Ugurlucan

BackgroundExtracranial internal carotid artery aneurysms are rare entities that arise within the carotid triangle. Although rare, they are clinically significant due to the risk of neurologic thromboembolic events, compression of cranial nerves and vasculature, rupture, and ischemia.ObjectiveSurgery is the gold-standard treatment for symptomatic patients of all ages with extracranial internal carotid artery aneurysm.MethodA 26-year-old female patient was admitted to our institution with complaints of left auricular pain, hoarseness, and uncontrollable hypertension. She had a pulsatile mass located at the left cervical region. After diagnosing the extracranial internal carotid artery aneurysm, it was decided that surgery was necessary to relieve the patient's discomfort and prevent possible complications from the aneurysm in the left carotid artery.ResultIn the operation, the aneurysmatic segment was resected and sent for histopathological evaluation. Saphenous vein graft was interposed as end to end anastomosis to the proximal and distal healthy segments of the internal carotid artery.ConclusionThis case report highlights the surgical management of a 26-year-old female patient who presented to our institution with complaints of left auricular pain, hoarseness, uncontrolled hypertension, and a pulsatile mass localized at the left cervical region and diagnosed extracranial internal carotid artery aneurysm.

背景:颅外颈内动脉瘤是发生在颈动脉三角内的罕见实体。虽然罕见,但由于存在神经系统血栓栓塞事件、压迫颅神经和血管、破裂和缺血的风险,因此具有重要的临床意义:手术是治疗有症状的各年龄段颅外颈内动脉瘤患者的金标准:一名 26 岁的女性患者因主诉左耳疼痛、声音嘶哑和无法控制的高血压而入住我院。她的左颈部有一个搏动性肿块。在诊断出颅内颈内动脉瘤后,医生决定必须进行手术治疗,以缓解患者的不适症状,并防止左侧颈内动脉瘤可能引发的并发症:手术切除了动脉瘤部分,并送去进行组织病理学评估。结果:手术中,动脉瘤部分被切除,并送去进行组织病理学评估,无隐静脉移植作为端对端吻合器与颈内动脉的近端和远端健康部分相连:本病例报告重点介绍了一名 26 岁女性患者的手术治疗情况,该患者因主诉左耳疼痛、声音嘶哑、高血压未得到控制、左颈部局部有搏动性肿块而到我院就诊,诊断为颅外颈内动脉瘤。
{"title":"Extracranial internal carotid artery aneurysm: Surgical approach to a rare entity.","authors":"Didem Melis Oztas, Seckin Cobanoglu, Asli Cakir, Okan Kuguoglu, Emre Oteyaka, Murat Ugurlucan","doi":"10.1177/17085381241290634","DOIUrl":"10.1177/17085381241290634","url":null,"abstract":"<p><p>BackgroundExtracranial internal carotid artery aneurysms are rare entities that arise within the carotid triangle. Although rare, they are clinically significant due to the risk of neurologic thromboembolic events, compression of cranial nerves and vasculature, rupture, and ischemia.ObjectiveSurgery is the gold-standard treatment for symptomatic patients of all ages with extracranial internal carotid artery aneurysm.MethodA 26-year-old female patient was admitted to our institution with complaints of left auricular pain, hoarseness, and uncontrollable hypertension. She had a pulsatile mass located at the left cervical region. After diagnosing the extracranial internal carotid artery aneurysm, it was decided that surgery was necessary to relieve the patient's discomfort and prevent possible complications from the aneurysm in the left carotid artery.ResultIn the operation, the aneurysmatic segment was resected and sent for histopathological evaluation. Saphenous vein graft was interposed as end to end anastomosis to the proximal and distal healthy segments of the internal carotid artery.ConclusionThis case report highlights the surgical management of a 26-year-old female patient who presented to our institution with complaints of left auricular pain, hoarseness, uncontrolled hypertension, and a pulsatile mass localized at the left cervical region and diagnosed extracranial internal carotid artery aneurysm.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1407-1414"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing anticoagulant therapy alone, anticoagulant therapy in combination with catheter-directed thrombolysis, and anticoagulant therapy in combination with pharmacomechanical catheter-directed thrombolysis in the patients with optional inferior vena cava filter-related thrombosis: A single-center retrospective study. 在可选的下腔静脉滤器相关血栓形成患者中,比较单纯抗凝疗法、抗凝疗法与导管引导溶栓相结合,以及抗凝疗法与药物机械导管引导溶栓相结合:单中心回顾性研究
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-12-01 Epub Date: 2024-10-12 DOI: 10.1177/17085381241289825
Zhaoyang Li, Zhicheng Duan, Huitang Yang, Meng Li, Yandong Cai, Zhan Jiang, Guoju Fan, Kaiqiang Wang, Bo Chen, Hongwei Zhang, Yankui Li
<p><p>ObjectiveTo analyze the treatment methods and efficacy of inferior vena cava filter thrombosis (IVCFT).Materials and methodsIn this retrospective study, the clinical data for 47 patients with IVCFT who underwent sequential treatment at the Department of Vascular Surgery, Tianjin Medical University Second Hospital, from January 2020 to January 2023 were analyzed. Patients were divided into three groups according to the treatment method: anticoagulant therapy (AC group), anticoagulation plus catheter-directed thrombolysis (CDT group), and anticoagulation plus AngioJet thrombectomy plus catheter-directed thrombolysis (PCDT group). The evaluation criteria for efficacy mainly included preoperative and postoperative clinical symptoms (Villalta score), thrombus diameter, thrombus clearance rate, filter retrieval rate, filter retention time, and urokinase dosage.ResultsThis study included 47 patients, of whom 31 were males (65.9%) and 16 females (34.1%), with a mean age of 72.05 ± 8.32 years. An Aegisy filter was used in seven patients, whereas an Illicium filter was used in forty patients. There were a total of nineteen patients in the anticoagulation-only group, with complete dissolution of the intraluminal thrombus in five patients, a residual thrombus with a maximum diameter ≤1 cm in three patients, and a residual thrombus with a maximum diameter >1 cm in eleven patients. The Villalta score was 7.16 ± 0.6 before treatment and decreased to 3.79 ± 0.59 after treatment. The thrombus diameter decreased from an average of 1.46 ± 0.2 cm before treatment to an average of 0.85 ± 0.14 cm after treatment. The retrieval rate for the filters was 42.11% (8/19), with an average dwell time of 27.4 ± 1.3 days for the filters. The CDT group consisted of 17 patients. Among whom we observed, complete dissolution of the intraluminal thrombus was observed in six patients, residual thrombus with a maximum diameter ≤1 cm in nine patients, and residual thrombus with a maximum diameter >1 cm in two patients. The Villalta score decreased from 7.53 ± 0.83 before treatment to 2.06 ± 0.39 after treatment. The thrombus diameter also decreased from 1.46 ± 0.16 cm before treatment to 0.35 ± 0.11 cm after treatment. The retrieval rate of the filters was 88.24% (15/17), and the average filter indwelling time was 19.25 ± 4.5 days. The PCDT group consisted of 11 patients. We observed complete dissolution of the intraluminal thrombus in four patients, residual thrombus with a maximum diameter ≤1 cm in six patients, and residual thrombus with a maximum diameter >1 cm in one patient. The Villalta score decreased from 7.45 ± 0.76 before treatment to 2.09 ± 0.55 after treatment. The thrombus diameter decreased from 1.50 ± 0.21 cm before treatment to 0.33 ± 0.35 cm after treatment, and the rate of filter retrieval was 90.91% (10/11).ConclusionThe three treatments of anticoagulation therapy, CDT, and PCDT were meaningful for preoperative and postoperative thrombolysis and symptom improv
目的:分析下腔静脉滤器血栓形成的治疗方法和疗效:分析下腔静脉滤器血栓(IVCFT)的治疗方法和疗效:本回顾性研究分析了2020年1月至2023年1月在天津医科大学第二医院血管外科接受序贯治疗的47例IVCFT患者的临床资料。根据治疗方法将患者分为三组:抗凝治疗组(AC 组)、抗凝加导管引导溶栓治疗组(CDT 组)和抗凝加 AngioJet 取栓加导管引导溶栓治疗组(PCDT 组)。疗效评估标准主要包括术前和术后临床症状(Villalta评分)、血栓直径、血栓清除率、滤器取栓率、滤器保留时间和尿激酶用量:本研究共纳入 47 例患者,其中男性 31 例(65.9%),女性 16 例(34.1%),平均年龄(72.05±8.32)岁。七名患者使用了 Aegisy 过滤器,四十名患者使用了 Illicium 过滤器。单纯抗凝组共有 19 名患者,其中 5 名患者的腔内血栓完全溶解,3 名患者的残余血栓最大直径≤1 厘米,11 名患者的残余血栓最大直径大于 1 厘米。治疗前的 Villalta 评分为 7.16 ± 0.6,治疗后降至 3.79 ± 0.59。血栓直径从治疗前的平均 1.46 ± 0.2 厘米降至治疗后的平均 0.85 ± 0.14 厘米。滤器取回率为 42.11%(8/19),滤器平均停留时间为 27.4 ± 1.3 天。CDT 组有 17 名患者。我们观察到,其中 6 名患者的腔内血栓完全溶解,9 名患者的残余血栓最大直径≤1 厘米,2 名患者的残余血栓最大直径大于 1 厘米。Villalta 评分从治疗前的 7.53 ± 0.83 降至治疗后的 2.06 ± 0.39。血栓直径也从治疗前的 1.46 ± 0.16 厘米降至治疗后的 0.35 ± 0.11 厘米。滤器取回率为 88.24%(15/17),滤器平均留置时间为 19.25 ± 4.5 天。PCDT 组有 11 名患者。我们观察到 4 名患者的腔内血栓完全溶解,6 名患者的残余血栓最大直径≤1 厘米,1 名患者的残余血栓最大直径大于 1 厘米。Villalta 评分从治疗前的 7.45 ± 0.76 降至治疗后的 2.09 ± 0.55。血栓直径从治疗前的 1.50 ± 0.21 厘米降至治疗后的 0.33 ± 0.35 厘米,滤器取出率为 90.91%(10/11):结论:抗凝治疗、CDT和PCDT三种治疗方法对IVCFT患者术前和术后溶栓及症状改善均有意义。CDT 和 PCDT 的应用优于抗凝疗法,而 CDT 组和 PCDT 组之间无明显差异。抗凝治疗组的滤器取回率最低,CDT 组和 PCDT 组之间无明显差异。
{"title":"Comparing anticoagulant therapy alone, anticoagulant therapy in combination with catheter-directed thrombolysis, and anticoagulant therapy in combination with pharmacomechanical catheter-directed thrombolysis in the patients with optional inferior vena cava filter-related thrombosis: A single-center retrospective study.","authors":"Zhaoyang Li, Zhicheng Duan, Huitang Yang, Meng Li, Yandong Cai, Zhan Jiang, Guoju Fan, Kaiqiang Wang, Bo Chen, Hongwei Zhang, Yankui Li","doi":"10.1177/17085381241289825","DOIUrl":"10.1177/17085381241289825","url":null,"abstract":"&lt;p&gt;&lt;p&gt;ObjectiveTo analyze the treatment methods and efficacy of inferior vena cava filter thrombosis (IVCFT).Materials and methodsIn this retrospective study, the clinical data for 47 patients with IVCFT who underwent sequential treatment at the Department of Vascular Surgery, Tianjin Medical University Second Hospital, from January 2020 to January 2023 were analyzed. Patients were divided into three groups according to the treatment method: anticoagulant therapy (AC group), anticoagulation plus catheter-directed thrombolysis (CDT group), and anticoagulation plus AngioJet thrombectomy plus catheter-directed thrombolysis (PCDT group). The evaluation criteria for efficacy mainly included preoperative and postoperative clinical symptoms (Villalta score), thrombus diameter, thrombus clearance rate, filter retrieval rate, filter retention time, and urokinase dosage.ResultsThis study included 47 patients, of whom 31 were males (65.9%) and 16 females (34.1%), with a mean age of 72.05 ± 8.32 years. An Aegisy filter was used in seven patients, whereas an Illicium filter was used in forty patients. There were a total of nineteen patients in the anticoagulation-only group, with complete dissolution of the intraluminal thrombus in five patients, a residual thrombus with a maximum diameter ≤1 cm in three patients, and a residual thrombus with a maximum diameter &gt;1 cm in eleven patients. The Villalta score was 7.16 ± 0.6 before treatment and decreased to 3.79 ± 0.59 after treatment. The thrombus diameter decreased from an average of 1.46 ± 0.2 cm before treatment to an average of 0.85 ± 0.14 cm after treatment. The retrieval rate for the filters was 42.11% (8/19), with an average dwell time of 27.4 ± 1.3 days for the filters. The CDT group consisted of 17 patients. Among whom we observed, complete dissolution of the intraluminal thrombus was observed in six patients, residual thrombus with a maximum diameter ≤1 cm in nine patients, and residual thrombus with a maximum diameter &gt;1 cm in two patients. The Villalta score decreased from 7.53 ± 0.83 before treatment to 2.06 ± 0.39 after treatment. The thrombus diameter also decreased from 1.46 ± 0.16 cm before treatment to 0.35 ± 0.11 cm after treatment. The retrieval rate of the filters was 88.24% (15/17), and the average filter indwelling time was 19.25 ± 4.5 days. The PCDT group consisted of 11 patients. We observed complete dissolution of the intraluminal thrombus in four patients, residual thrombus with a maximum diameter ≤1 cm in six patients, and residual thrombus with a maximum diameter &gt;1 cm in one patient. The Villalta score decreased from 7.45 ± 0.76 before treatment to 2.09 ± 0.55 after treatment. The thrombus diameter decreased from 1.50 ± 0.21 cm before treatment to 0.33 ± 0.35 cm after treatment, and the rate of filter retrieval was 90.91% (10/11).ConclusionThe three treatments of anticoagulation therapy, CDT, and PCDT were meaningful for preoperative and postoperative thrombolysis and symptom improv","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1441-1449"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence. 颈动脉体肿瘤手术的长期效果以及对转移性疾病和复发的预测分析。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-12-01 Epub Date: 2024-11-01 DOI: 10.1177/17085381241297067
Najibullah I Verdikhanov, Andrey V Chupin, Irina E Timina, Zaurbek A Adyrkhaev
<p><p>ObjectiveThe determination of clinico-surgical predictors of carotid body tumour (CBT) metastasizing and/or recurrence.MethodsPatients with CBT but without a history of its previous treatment who had received inpatient medical aid at a tertiary surgical centre during the period 2011-2021 were retrospectively reviewed to obtain baseline data. Primary endpoints of the study were CBT metastasizing and/or local recurrence after radical surgery (composite endpoint) and overall survival. Secondary endpoint of the study was primary patency of carotid arteries that had been repaired/reconstructed as a result of CBT removal. Suspected predictors of CBT metastasizing/recurrence were young age of CBT onset, positive family history, multifocal paraganglioma, Shamblin type III CBT, carotid bifurcation and/or internal carotid artery (ICA) reconstruction as a result of CBT excision. To detect CBT metastasizing/recurrence, prospective imaging-based whole-body screening was suggested to patients.ResultsFifty-three patients met the eligibility criteria. The overall survival rate was 100% at a median follow-up time of 68 months (interquartile range [IQR] 27‒104.5 months). The primary patency of repaired carotid arteries (<i>n</i> = 9) was 88.9% at a median follow-up time of 99 months (IQR 15.5‒116.5 months). Thirty-nine patients underwent the prospective whole-body screening. Eight (20.5%) patients were diagnosed with metastatic disease (<i>n</i> = 6) or local recurrence (<i>n</i> = 2). Patients with CBT metastasizing/recurrence were younger at age of CBT onset (<i>p</i> = .011), more frequently had Shamblin type III CBT (<i>p</i> = .004) and the necessity for carotid artery repair/reconstruction (<i>p</i> = .041) than patients without metastasizing/recurrence. These two groups were similar in terms of gender (<i>p</i> = .682), the prevalence of multifocal paraganglioma (<i>p</i> = .167) and positive family history (<i>p</i> = .180). Only the belonging of a CBT to Shamblin type III was defined as a statistically significant predictor of CBT metastasizing/recurrence in both univariable and multivariable binary logistic regression analyses (odds ratio 30; 95% confidence interval: 2.649-339.739; <i>p</i> = .006 and odds ratio 75.409; 95% confidence interval: 1.082-5254.557; <i>p</i> = .046, respectively). Multifocal paraganglioma as a predictor exhibited a strong tendency towards statistical significance (<i>p</i> = .09 and <i>p</i> = .072, respectively). Other suspected predictors didn't reach the level of statistical significance either in univariable (<i>p</i> = .151 for positive family history) or in multivariable (<i>p</i> = .211 for age of CBT onset; <i>p</i> = .734 for carotid artery reconstruction/repair) binary logistic regression analyses.ConclusionShamblin type III CBT has high potential for metastasizing and recurrence. Patients with Shamblin type III CBT and/or multifocal paraganglioma should be considered for genetic testing as well as preoperative
目的:确定颈动脉体肿瘤(CBT)转移和/或复发的临床手术预测因素:确定颈动脉体肿瘤(CBT)转移和/或复发的临床手术预测因素:对 2011-2021 年期间在一家三级外科中心接受住院医疗救助的 CBT 患者进行回顾性研究,以获得基线数据。研究的主要终点是CBT转移和/或根治术后局部复发(复合终点)和总生存期。研究的次要终点是因CBT切除而修复/重建的颈动脉的主要通畅性。CBT转移/复发的可疑预测因素包括:CBT发病年龄小、阳性家族史、多灶性副神经节瘤、Shamblin III型CBT、CBT切除后颈动脉分叉和/或颈内动脉(ICA)重建。为检测CBT转移/复发,建议患者进行基于影像学的前瞻性全身筛查:结果:53 名患者符合资格标准。中位随访时间为 68 个月(四分位间距 [IQR] 27-104.5 个月),总生存率为 100%。中位随访时间为 99 个月(IQR 15.5-116.5 个月),修复后颈动脉(9 例)的初次通畅率为 88.9%。39 名患者接受了前瞻性全身筛查。8例(20.5%)患者被诊断为转移性疾病(6例)或局部复发(2例)。与没有转移/复发的患者相比,CBT 转移/复发患者的发病年龄更小(p = .011),更经常出现 Shamblin III 型 CBT(p = .004)和颈动脉修复/重建的必要性(p = .041)。这两组患者在性别(p = .682)、多灶性副神经管瘤患病率(p = .167)和阳性家族史(p = .180)方面相似。在单变量和多变量二元逻辑回归分析中,只有属于 Shamblin III 型的 CBT 被定义为具有统计学意义的 CBT 转移/复发预测因子(分别为几率比 30;95% 置信区间:2.649-339.739;p = .006 和几率比 75.409;95% 置信区间:1.082-5254.557;p = .046)。多灶性副神经节瘤作为一种预测因子,显示出较强的统计显著性趋势(分别为 p = .09 和 p = .072)。在单变量(阳性家族史的 p = .151)或多变量(CBT 发病年龄的 p = .211;颈动脉重建/修复的 p = .734)二元逻辑回归分析中,其他可疑预测因子均未达到统计学意义水平:结论:Shamblin III 型 CBT 转移和复发的可能性很大。结论:Shamblin III 型 CBT 和/或多灶性副神经节瘤患者应考虑进行基因检测以及术前全身放射成像和术后长期全身成像随访。
{"title":"Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence.","authors":"Najibullah I Verdikhanov, Andrey V Chupin, Irina E Timina, Zaurbek A Adyrkhaev","doi":"10.1177/17085381241297067","DOIUrl":"10.1177/17085381241297067","url":null,"abstract":"&lt;p&gt;&lt;p&gt;ObjectiveThe determination of clinico-surgical predictors of carotid body tumour (CBT) metastasizing and/or recurrence.MethodsPatients with CBT but without a history of its previous treatment who had received inpatient medical aid at a tertiary surgical centre during the period 2011-2021 were retrospectively reviewed to obtain baseline data. Primary endpoints of the study were CBT metastasizing and/or local recurrence after radical surgery (composite endpoint) and overall survival. Secondary endpoint of the study was primary patency of carotid arteries that had been repaired/reconstructed as a result of CBT removal. Suspected predictors of CBT metastasizing/recurrence were young age of CBT onset, positive family history, multifocal paraganglioma, Shamblin type III CBT, carotid bifurcation and/or internal carotid artery (ICA) reconstruction as a result of CBT excision. To detect CBT metastasizing/recurrence, prospective imaging-based whole-body screening was suggested to patients.ResultsFifty-three patients met the eligibility criteria. The overall survival rate was 100% at a median follow-up time of 68 months (interquartile range [IQR] 27‒104.5 months). The primary patency of repaired carotid arteries (&lt;i&gt;n&lt;/i&gt; = 9) was 88.9% at a median follow-up time of 99 months (IQR 15.5‒116.5 months). Thirty-nine patients underwent the prospective whole-body screening. Eight (20.5%) patients were diagnosed with metastatic disease (&lt;i&gt;n&lt;/i&gt; = 6) or local recurrence (&lt;i&gt;n&lt;/i&gt; = 2). Patients with CBT metastasizing/recurrence were younger at age of CBT onset (&lt;i&gt;p&lt;/i&gt; = .011), more frequently had Shamblin type III CBT (&lt;i&gt;p&lt;/i&gt; = .004) and the necessity for carotid artery repair/reconstruction (&lt;i&gt;p&lt;/i&gt; = .041) than patients without metastasizing/recurrence. These two groups were similar in terms of gender (&lt;i&gt;p&lt;/i&gt; = .682), the prevalence of multifocal paraganglioma (&lt;i&gt;p&lt;/i&gt; = .167) and positive family history (&lt;i&gt;p&lt;/i&gt; = .180). Only the belonging of a CBT to Shamblin type III was defined as a statistically significant predictor of CBT metastasizing/recurrence in both univariable and multivariable binary logistic regression analyses (odds ratio 30; 95% confidence interval: 2.649-339.739; &lt;i&gt;p&lt;/i&gt; = .006 and odds ratio 75.409; 95% confidence interval: 1.082-5254.557; &lt;i&gt;p&lt;/i&gt; = .046, respectively). Multifocal paraganglioma as a predictor exhibited a strong tendency towards statistical significance (&lt;i&gt;p&lt;/i&gt; = .09 and &lt;i&gt;p&lt;/i&gt; = .072, respectively). Other suspected predictors didn't reach the level of statistical significance either in univariable (&lt;i&gt;p&lt;/i&gt; = .151 for positive family history) or in multivariable (&lt;i&gt;p&lt;/i&gt; = .211 for age of CBT onset; &lt;i&gt;p&lt;/i&gt; = .734 for carotid artery reconstruction/repair) binary logistic regression analyses.ConclusionShamblin type III CBT has high potential for metastasizing and recurrence. Patients with Shamblin type III CBT and/or multifocal paraganglioma should be considered for genetic testing as well as preoperative","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1424-1431"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the knowledge of ChatGPT and Google Gemini in answering peripheral artery disease-related questions. 评估ChatGPT和谷歌Gemini在回答外周动脉疾病相关问题中的知识。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-12-01 Epub Date: 2025-01-21 DOI: 10.1177/17085381251315999
Hakkı Kursat Cetin, Tolga Demir

IntroductionTo assess and compare the knowledge of ChatGPT and Google Gemini in answering public-based and scientific questions about peripheral artery disease (PAD).MethodsFrequently asked questions (FAQs) about PAD were generated by evaluating posts on social media, and the latest edition of the European Society of Cardiology (ESC) guideline was evaluated and recommendations about PAD were translated into questions. All questions were prepared in English and were asked to ChatGPT 4 and Google Gemini (formerly Google Bard) applications. The specialists assigned a Global Quality Score (GQS) for each response.ResultsFinally, 72 FAQs and 63 ESC guideline-based questions were identified. In total, 51 (70.8%) answers by ChatGPT for FAQs were categorized as GQS 5. Moreover, 44 (69.8%) ChatGPT answers to ESC guideline-based questions about PAD scored GQS 5. A total of 40 (55.6%) answers by Google Gemini for FAQs related with PAD obtained GQS 5. In addition, 50.8% (32 of 63) Google Gemini answers to ESC guideline-based questions were classified as GQS 5. Comparison of ChatGPT and Google Gemini with regards to GQS score revealed that both for FAQs about PAD, and ESC guideline-based scientific questions about PAD, ChatGPT gave more accurate and satisfactory answers (p = 0.031 and p = 0.026). In contrast, response time was significantly shorter for Google Gemini for both FAQs and scientific questions about PAD (p = 0.008 and p = 0.001).ConclusionOur findings revealed that both ChatGPT and Google Gemini had limited capacity to answer FAQs and scientific questions related with PDA, but accuracy and satisfactory rate of answers for both FAQs and scientific questions about PAD were significantly higher in favor of ChatGPT.

目的:评估和比较ChatGPT和谷歌Gemini在回答有关外周动脉疾病(PAD)的公众和科学问题方面的知识。方法:通过对社交媒体上的帖子进行评价,生成有关PAD的常见问题(FAQs),并对最新版欧洲心脏病学会(ESC)指南进行评价,将有关PAD的建议转化为问题。所有问题都是用英语准备的,并被要求参加gpt 4和谷歌双子座(以前是谷歌巴德)申请。专家们为每个回答分配了一个全球质量分数(GQS)。结果:最终确定了72个常见问题和63个ESC指南问题。在ChatGPT的常见问题解答中,共有51个(70.8%)被归类为GQS 5。此外,有44个(69.8%)ChatGPT在ESC指南基础问题中获得GQS 5分。谷歌Gemini对PAD相关常见问题的回答中,有40个(55.6%)获得了GQS 5。此外,50.8%(63个问题中的32个)双子座回答的ESC指南基础问题被归类为GQS 5。ChatGPT与谷歌Gemini在GQS评分方面的比较显示,无论是对于PAD的常见问题,还是基于ESC指南的关于PAD的科学问题,ChatGPT给出的答案都更加准确和令人满意(p = 0.031和p = 0.026)。相比之下,谷歌Gemini在关于PAD的常见问题和科学问题上的反应时间明显更短(p = 0.008和p = 0.001)。结论:ChatGPT和谷歌Gemini对PDA相关的常见问题和科学问题的回答能力有限,但ChatGPT对PAD相关的常见问题和科学问题的回答准确率和满意率均明显高于谷歌Gemini。
{"title":"Assessing the knowledge of ChatGPT and Google Gemini in answering peripheral artery disease-related questions.","authors":"Hakkı Kursat Cetin, Tolga Demir","doi":"10.1177/17085381251315999","DOIUrl":"10.1177/17085381251315999","url":null,"abstract":"<p><p>IntroductionTo assess and compare the knowledge of ChatGPT and Google Gemini in answering public-based and scientific questions about peripheral artery disease (PAD).MethodsFrequently asked questions (FAQs) about PAD were generated by evaluating posts on social media, and the latest edition of the European Society of Cardiology (ESC) guideline was evaluated and recommendations about PAD were translated into questions. All questions were prepared in English and were asked to ChatGPT 4 and Google Gemini (formerly Google Bard) applications. The specialists assigned a Global Quality Score (GQS) for each response.ResultsFinally, 72 FAQs and 63 ESC guideline-based questions were identified. In total, 51 (70.8%) answers by ChatGPT for FAQs were categorized as GQS 5. Moreover, 44 (69.8%) ChatGPT answers to ESC guideline-based questions about PAD scored GQS 5. A total of 40 (55.6%) answers by Google Gemini for FAQs related with PAD obtained GQS 5. In addition, 50.8% (32 of 63) Google Gemini answers to ESC guideline-based questions were classified as GQS 5. Comparison of ChatGPT and Google Gemini with regards to GQS score revealed that both for FAQs about PAD, and ESC guideline-based scientific questions about PAD, ChatGPT gave more accurate and satisfactory answers (<i>p</i> = 0.031 and <i>p</i> = 0.026). In contrast, response time was significantly shorter for Google Gemini for both FAQs and scientific questions about PAD (<i>p</i> = 0.008 and <i>p</i> = 0.001).ConclusionOur findings revealed that both ChatGPT and Google Gemini had limited capacity to answer FAQs and scientific questions related with PDA, but accuracy and satisfactory rate of answers for both FAQs and scientific questions about PAD were significantly higher in favor of ChatGPT.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1282-1287"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of negative pressure wound therapy (PICO) and standard dressing application after arterial vascular reconstructions. 动脉血管重建后负压伤口疗法(PICO)与标准敷料应用的比较分析。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-12-01 Epub Date: 2024-10-26 DOI: 10.1177/17085381241296606
Valentyna Kostiuk, Soraya Fereydooni, Ocean Setia, Sarah A Loh, David Strosberg, Britt H Tonnessen, Cassius Iyad Ochoa Chaar, Edouard Aboian

IntroductionSurgical site infections following arterial reconstructions with femoral exposures are common and potentially preventable. Negative pressure wound therapy has emerged as a potential solution to minimize groin wound complications. Our study evaluates efficacy of a negative pressure therapy (PICO dressing) in reducing groin wound complications after vascular reconstructions.MethodsA retrospective single center comparative analysis of vascular reconstructions involving common femoral artery dissection was performed between July 2021 and June 2023. Patients were divided into two groups: patients treated with PICO device and patients who received standard dressing (non-PICO). Patient demographics, comorbidities, vascular evaluation, and procedure indications were compared. Previous interventions, incision orientation and procedure types were noted. The wound complication categories were graded according to the Szilagyi classification: grade 1 (superficial infection/minor dehiscence), grade 2 (deep infection/major dehiscence), and grade 3 (artery or prosthetic involvement). Statistical significance level was determined at p < .05 for all analyses.ResultsA total of 217 groin dissections in 184 patients were analyzed with 132 and 85 groin dissections in the PICO and non-PICO groups, respectively. The baseline characteristics were similar between the groups in terms of age, sex, BMI, and procedure indications. Prior endovascular procedures and re-operative groin surgeries were more prevalent in the PICO group. The use of antibiotics post-operatively for groin wound complication was greater in the non-PICO group. The incidence of wound complications was higher in the non-PICO group (29.4% vs 10.6%, p < .001). Multivariate logistic regression analysis determined that PICO dressing as well as hybrid and endovascular index procedures were associated with lower risks of groin complications.ConclusionPICO dressing decreased the incidence of groin wound complications in patients undergoing open vascular reconstructions. This study highlights the value of adjunctive negative pressure therapy in reduction of wound complications after arterial reconstructions in the inguinal region.

导言:股外露动脉重建术后的手术部位感染很常见,而且可能是可以预防的。负压伤口疗法已成为减少腹股沟伤口并发症的潜在解决方案。我们的研究评估了负压疗法(PICO 敷料)在减少血管重建术后腹股沟伤口并发症方面的疗效:方法:我们在 2021 年 7 月至 2023 年 6 月期间对涉及股总动脉夹层的血管重建进行了回顾性单中心比较分析。患者分为两组:使用 PICO 装置治疗的患者和使用标准敷料(非 PICO)治疗的患者。比较了患者的人口统计学特征、合并症、血管评估和手术适应症。同时还记录了之前的干预措施、切口方向和手术类型。根据 Szilagyi 分类法对伤口并发症进行了分级:1 级(浅表感染/轻度开裂)、2 级(深度感染/严重开裂)和 3 级(动脉或假体受累)。所有分析的统计学意义均以 p < .05 为标准:共对 184 名患者的 217 例腹股沟撕裂进行了分析,其中 PICO 组和非 PICO 组分别有 132 例和 85 例腹股沟撕裂。两组患者在年龄、性别、体重指数和手术适应症方面的基线特征相似。在 PICO 组中,既往接受过血管内手术和腹股沟再次手术的比例更高。非 PICO 组术后因腹股沟伤口并发症使用抗生素的比例更高。非 PICO 组的伤口并发症发生率更高(29.4% vs 10.6%,p < .001)。多变量逻辑回归分析表明,PICO敷料以及杂交和血管内指数手术与较低的腹股沟并发症风险相关:结论:PICO 敷料降低了开放血管重建患者腹股沟伤口并发症的发生率。这项研究强调了辅助负压疗法在减少腹股沟区域动脉重建术后伤口并发症方面的价值。
{"title":"Comparative analysis of negative pressure wound therapy (PICO) and standard dressing application after arterial vascular reconstructions.","authors":"Valentyna Kostiuk, Soraya Fereydooni, Ocean Setia, Sarah A Loh, David Strosberg, Britt H Tonnessen, Cassius Iyad Ochoa Chaar, Edouard Aboian","doi":"10.1177/17085381241296606","DOIUrl":"10.1177/17085381241296606","url":null,"abstract":"<p><p>IntroductionSurgical site infections following arterial reconstructions with femoral exposures are common and potentially preventable. Negative pressure wound therapy has emerged as a potential solution to minimize groin wound complications. Our study evaluates efficacy of a negative pressure therapy (PICO dressing) in reducing groin wound complications after vascular reconstructions.MethodsA retrospective single center comparative analysis of vascular reconstructions involving common femoral artery dissection was performed between July 2021 and June 2023. Patients were divided into two groups: patients treated with PICO device and patients who received standard dressing (non-PICO). Patient demographics, comorbidities, vascular evaluation, and procedure indications were compared. Previous interventions, incision orientation and procedure types were noted. The wound complication categories were graded according to the Szilagyi classification: grade 1 (superficial infection/minor dehiscence), grade 2 (deep infection/major dehiscence), and grade 3 (artery or prosthetic involvement). Statistical significance level was determined at <i>p</i> < .05 for all analyses.ResultsA total of 217 groin dissections in 184 patients were analyzed with 132 and 85 groin dissections in the PICO and non-PICO groups, respectively. The baseline characteristics were similar between the groups in terms of age, sex, BMI, and procedure indications. Prior endovascular procedures and re-operative groin surgeries were more prevalent in the PICO group. The use of antibiotics post-operatively for groin wound complication was greater in the non-PICO group. The incidence of wound complications was higher in the non-PICO group (29.4% vs 10.6%, <i>p</i> < .001). Multivariate logistic regression analysis determined that PICO dressing as well as hybrid and endovascular index procedures were associated with lower risks of groin complications.ConclusionPICO dressing decreased the incidence of groin wound complications in patients undergoing open vascular reconstructions. This study highlights the value of adjunctive negative pressure therapy in reduction of wound complications after arterial reconstructions in the inguinal region.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1304-1310"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142508964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poor adherence to ultrasound surveillance is associated with infrainguinal bypass graft failure - An ongoing challenge in Australia. 超声监测依从性差与腹股沟下旁路移植失败有关-这是澳大利亚的一个持续挑战。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-12-01 Epub Date: 2024-12-12 DOI: 10.1177/17085381241307754
Mei Ping Melody Koo, Hansraj Riteesh Bookun

BackgroundsInfra-inguinal bypass (IIB) surgery is a time-proven and reliable management avenue for the treatment of peripheral arterial disease (PAD). The importance of ultrasound surveillance in maintaining IIB graft patency is well-recognised, yet adherence rates are underreported. This study evaluates the impact of surveillance compliance on graft outcomes in an Australian setting.MethodsA cross-sectional analysis of IIBs performed between 2010 and 2020 at a major vascular surgical institution in Australia was conducted retrospectively. Demographic data, peri-operative comorbidities and configuration of the bypass were captured as well as post-discharge results. Surveillance compliance was assessed based on adherence to post-operative ultrasound and clinic visits. The chief outcome measure was graft occlusion within 2 years. Secondary outcomes were major amputation, mortality and ambulatory function.ResultsOver a time period of 10 years, 239 bypasses were carried out on 207 individuals. 83% complied with surveillance protocols. Adherence rates were lower in regional patients. Non-compliance was significantly associated with vein graft occlusions (p < 0.01) but not with synthetic grafts. Regional referrals (p < 0.01), low pre-operative haemoglobin (p < 0.01), post-operative transfusion (p = 0.02) and use of prosthetic conduit (p < 0.01) were identified as significant predictors of graft thrombosis. Patients with occluded grafts were at substantially higher risk of ambulatory deterioration (2.4 fold), major limb amputation or death (8.6 fold) within 12 months. One-year survival without amputation was 88.3%.ConclusionEnhanced bypass graft surveillance is essential in clinical practice to minimise graft occlusion, reduction in morbidity, limb loss and death. This study reveals suboptimal compliance in Australian vascular surgical setting, particularly in regional areas, underscoring the need for improved education, resource allocation and infrastructural development.

背景:腹股沟下旁路(IIB)手术是治疗外周动脉疾病(PAD)的一种经过时间验证和可靠的管理途径。超声监测在维持IIB移植通畅中的重要性是公认的,但依从率被低估。本研究评估了在澳大利亚环境下监督依从性对贪污结果的影响。方法:回顾性分析2010年至2020年在澳大利亚一家主要血管外科机构进行的iib横断面分析。统计数据、围手术期合并症和旁路的配置以及出院后的结果被捕获。根据术后超声检查和门诊检查的依从性评估监测依从性。主要观察指标为2年内移植物闭塞。次要结局是主要截肢、死亡率和活动功能。结果:在10年的时间里,对207例患者进行了239次搭桥手术。83%的人遵守了监控协议。区域性患者的依从率较低。不依从性与静脉移植物闭塞有显著相关性(p < 0.01),而与合成移植物无显著相关性。地区转诊(p < 0.01)、术前低血红蛋白(p < 0.01)、术后输血(p = 0.02)和使用假体导管(p < 0.01)被认为是移植物血栓形成的重要预测因素。移植物闭塞的患者在12个月内发生动态恶化(2.4倍)、主要肢体截肢或死亡(8.6倍)的风险明显更高。不截肢的一年生存率为88.3%。结论:在临床实践中,加强搭桥监测对于减少移植物闭塞、减少发病率、肢体丧失和死亡至关重要。这项研究揭示了澳大利亚血管手术环境的次优依从性,特别是在区域地区,强调了改善教育、资源分配和基础设施发展的必要性。
{"title":"Poor adherence to ultrasound surveillance is associated with infrainguinal bypass graft failure - An ongoing challenge in Australia.","authors":"Mei Ping Melody Koo, Hansraj Riteesh Bookun","doi":"10.1177/17085381241307754","DOIUrl":"10.1177/17085381241307754","url":null,"abstract":"<p><p>BackgroundsInfra-inguinal bypass (IIB) surgery is a time-proven and reliable management avenue for the treatment of peripheral arterial disease (PAD). The importance of ultrasound surveillance in maintaining IIB graft patency is well-recognised, yet adherence rates are underreported. This study evaluates the impact of surveillance compliance on graft outcomes in an Australian setting.MethodsA cross-sectional analysis of IIBs performed between 2010 and 2020 at a major vascular surgical institution in Australia was conducted retrospectively. Demographic data, peri-operative comorbidities and configuration of the bypass were captured as well as post-discharge results. Surveillance compliance was assessed based on adherence to post-operative ultrasound and clinic visits. The chief outcome measure was graft occlusion within 2 years. Secondary outcomes were major amputation, mortality and ambulatory function.ResultsOver a time period of 10 years, 239 bypasses were carried out on 207 individuals. 83% complied with surveillance protocols. Adherence rates were lower in regional patients. Non-compliance was significantly associated with vein graft occlusions (<i>p</i> < 0.01) but not with synthetic grafts. Regional referrals (<i>p</i> < 0.01), low pre-operative haemoglobin (<i>p</i> < 0.01), post-operative transfusion (<i>p</i> = 0.02) and use of prosthetic conduit (<i>p</i> < 0.01) were identified as significant predictors of graft thrombosis. Patients with occluded grafts were at substantially higher risk of ambulatory deterioration (2.4 fold), major limb amputation or death (8.6 fold) within 12 months. One-year survival without amputation was 88.3%.ConclusionEnhanced bypass graft surveillance is essential in clinical practice to minimise graft occlusion, reduction in morbidity, limb loss and death. This study reveals suboptimal compliance in Australian vascular surgical setting, particularly in regional areas, underscoring the need for improved education, resource allocation and infrastructural development.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1380-1389"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of doxycycline in reducing MMP-9 and acute-phase reactants to limit abdominal aortic aneurysm growth: A systematic review. 强力霉素在减少MMP-9和急性期反应物以限制腹主动脉瘤生长中的作用:一项系统综述。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-10-30 DOI: 10.1177/17085381251379296
Luis Morales-Ojeda, Stefania Montero-Arcila, Leetha Paul, Victor Nunes, Emily A Malgor, Donald L Jacobs, Rafael D Malgor

BackgroundAbdominal aortic aneurysms (AAAs) are a significant vascular disease characterized by the degradation of medial elastic lamellae, neovascularization, and inflammatory responses. While surgical intervention remains the standard treatment for large or rapidly expanding AAAs, there is no universally accepted pharmacological therapy to prevent aneurysm progression. Matrix metalloproteinases (MMPs), particularly MMP-9, and inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) are implicated in AAA pathogenesis, making them potential therapeutic targets. Doxycycline, a broad-spectrum tetracycline antibiotic, has demonstrated inhibitory effects on MMP-9 and anti-inflammatory properties. However, its efficacy in slowing AAA progression remains unclear.MethodsA systematic review was conducted following PRISMA guidelines. Electronic searches were performed in PubMed, MEDLINE, EMBASE, and ClinicalTrials.gov. Inclusion criteria encompassed randomized controlled trials (RCTs), cohort studies, in vitro studies, and systematic reviews evaluating the effects of doxycycline on AAA growth. Data extraction was performed using Covidence software, and study quality was assessed using the Cochrane Risk of Bias Tool 2.0 (RoB2) for RCTs, the QUIN tool for in vitro studies, and the SYRCLE tool for animal experiments. Statistical analysis employed a random-effects model to evaluate heterogeneity among studies.ResultsThe initial search identified 1313 references, of which 10 studies met inclusion criteria: two RCTs, two systematic reviews, three in vitro studies, one in vivo study, one methodological study, and one experimental study. The two RCTs, involving 515 patients with an average age of 71 years, reported minimal to no significant reductions in AAA growth following doxycycline administration. In contrast, in vitro and in vivo studies demonstrated inhibition of MMP-9 and inflammatory markers, supporting doxycycline's potential therapeutic role. Meta-analysis was not performed due to high heterogeneity (I2 = 75%). Risk of bias assessment indicated a low risk for RCTs, whereas in vitro and in vivo studies showed a moderate risk of bias.ConclusionWhile doxycycline exhibits promising biochemical effects in AAA pathophysiology, its clinical efficacy remains uncertain. Current evidence does not support its routine use in AAA management outside clinical trials. Future research should focus on targeted pharmacotherapy integrating patient-specific biomarkers to enhance therapeutic outcomes.

腹主动脉瘤(AAAs)是一种重要的血管疾病,其特征是内侧弹性层退化、新生血管形成和炎症反应。虽然手术干预仍然是大型或迅速扩大的AAAs的标准治疗方法,但目前还没有普遍接受的药物治疗来预防动脉瘤的进展。基质金属蛋白酶(MMPs),特别是MMP-9和炎症标志物如高敏c反应蛋白(hs-CRP)与AAA发病机制有关,使其成为潜在的治疗靶点。强力霉素是一种广谱四环素类抗生素,具有抑制MMP-9和抗炎作用。然而,其减缓AAA进展的功效尚不清楚。方法按照PRISMA指南进行系统评价。电子检索在PubMed、MEDLINE、EMBASE和ClinicalTrials.gov中进行。纳入标准包括随机对照试验(rct)、队列研究、体外研究和评估强力霉素对AAA生长影响的系统评价。使用covid - ence软件进行数据提取,随机对照试验使用Cochrane风险偏倚工具2.0 (RoB2),体外研究使用QUIN工具,动物实验使用sycle工具评估研究质量。统计分析采用随机效应模型评价研究间的异质性。结果最初检索到1313篇文献,其中10项研究符合纳入标准:2项随机对照试验、2项系统综述、3项体外研究、1项体内研究、1项方法学研究和1项实验研究。这两项随机对照试验,涉及515名平均年龄为71岁的患者,报告了给予多西环素后AAA生长的最小或无显著减少。相比之下,体外和体内研究表明,多西环素对MMP-9和炎症标志物有抑制作用,支持多西环素的潜在治疗作用。由于异质性高(I2 = 75%),未进行meta分析。偏倚风险评估显示rct的风险较低,而体外和体内研究显示偏倚风险中等。结论强力霉素在AAA病理生理上具有良好的生化作用,但其临床疗效尚不明确。目前的证据不支持在临床试验之外的AAA治疗中常规使用。未来的研究应侧重于结合患者特异性生物标志物的靶向药物治疗,以提高治疗效果。
{"title":"The role of doxycycline in reducing MMP-9 and acute-phase reactants to limit abdominal aortic aneurysm growth: A systematic review.","authors":"Luis Morales-Ojeda, Stefania Montero-Arcila, Leetha Paul, Victor Nunes, Emily A Malgor, Donald L Jacobs, Rafael D Malgor","doi":"10.1177/17085381251379296","DOIUrl":"https://doi.org/10.1177/17085381251379296","url":null,"abstract":"<p><p>BackgroundAbdominal aortic aneurysms (AAAs) are a significant vascular disease characterized by the degradation of medial elastic lamellae, neovascularization, and inflammatory responses. While surgical intervention remains the standard treatment for large or rapidly expanding AAAs, there is no universally accepted pharmacological therapy to prevent aneurysm progression. Matrix metalloproteinases (MMPs), particularly MMP-9, and inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) are implicated in AAA pathogenesis, making them potential therapeutic targets. Doxycycline, a broad-spectrum tetracycline antibiotic, has demonstrated inhibitory effects on MMP-9 and anti-inflammatory properties. However, its efficacy in slowing AAA progression remains unclear.MethodsA systematic review was conducted following PRISMA guidelines. Electronic searches were performed in PubMed, MEDLINE, EMBASE, and ClinicalTrials.gov. Inclusion criteria encompassed randomized controlled trials (RCTs), cohort studies, in vitro studies, and systematic reviews evaluating the effects of doxycycline on AAA growth. Data extraction was performed using Covidence software, and study quality was assessed using the Cochrane Risk of Bias Tool 2.0 (RoB2) for RCTs, the QUIN tool for in vitro studies, and the SYRCLE tool for animal experiments. Statistical analysis employed a random-effects model to evaluate heterogeneity among studies.ResultsThe initial search identified 1313 references, of which 10 studies met inclusion criteria: two RCTs, two systematic reviews, three in vitro studies, one in vivo study, one methodological study, and one experimental study. The two RCTs, involving 515 patients with an average age of 71 years, reported minimal to no significant reductions in AAA growth following doxycycline administration. In contrast, in vitro and in vivo studies demonstrated inhibition of MMP-9 and inflammatory markers, supporting doxycycline's potential therapeutic role. Meta-analysis was not performed due to high heterogeneity (I<sup>2</sup> = 75%). Risk of bias assessment indicated a low risk for RCTs, whereas in vitro and in vivo studies showed a moderate risk of bias.ConclusionWhile doxycycline exhibits promising biochemical effects in AAA pathophysiology, its clinical efficacy remains uncertain. Current evidence does not support its routine use in AAA management outside clinical trials. Future research should focus on targeted pharmacotherapy integrating patient-specific biomarkers to enhance therapeutic outcomes.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251379296"},"PeriodicalIF":0.9,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145410236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of long-term clinical and anatomical results of endovenous cyanoacrylate embolization and endovenous laser ablation methods in the treatment of great saphenous vein insufficiency. 氰基丙烯酸酯内栓塞与激光消融治疗大隐静脉功能不全的长期临床与解剖效果比较。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-10-16 DOI: 10.1177/17085381251379841
Atilla Saraç

ObjectiveAlthough some publications are comparing the early clinical and anatomical results of endovenous laser ablation and endovenous cyanoacrylate embolization in great saphenous vein insufficiency, according to our knowledge, there are limited publications comparing the long-term clinical and anatomical results of these methods. I aimed to compare the long-term clinical and anatomical outcomes of these endovenous treatment methods.MethodsA total of 248 patients over the age of 18 who underwent endovenous laser ablation or endovenous cyanoacrylate embolization for the treatment of great saphenous vein insufficiency were included in the study. Patients who have been treated with a treatment method other than these methods were not included in this study. The equal numbers of patients were included in two groups according to the applied treatment methods. The groups were not fully matched in terms of baseline characteristics in this study, and significant differences were detected in age and preoperative reflux duration values (p < .05), and therefore, the results were re-analyzed with models (ANCOVA) adjusted for age and clinical severity parameters.ResultsEndovenous laser ablation or endovenous cyanoacrylate embolization procedures were performed in a total of 248 patients with a mean age of 51.22 ± 13.20 years. There was a statistically significant difference in mean age between the groups (p = .017). The mean preoperative CEAP score of study patients was 3.07 ± 0.57 (between 2 and 6), and the mean preoperative VCSS value was 6.85 ± 1.18. The average follow-up period of the study patients was 3.5 ± 0.50 years and at the end of the follow-up, a decrease in CEAP stage and VCSS values was observed in both groups.ConclusionsThe endovenous cyanoacrylate embolization offers similar long-term success rates to endovenous laser ablation, is a shorter procedure time, and offers advantages in returning to daily activities after the procedure. Both treatment methods, with effective and accessible healthcare systems, offer a variety of treatment options. The results of this study suggest that while both methods reduce the CEAP stage in the long term, endovenous cyanoacrylate embolization may provide a greater reduction. However, endovenous laser ablation may be more effective in reducing symptom severity (VCSS) and may offer an effective treatment option with lower complication rates and similar outpatient benefits and cost-effectiveness.

目的虽然有文献比较了静脉内激光消融与静脉内氰基丙烯酸酯栓塞治疗大隐静脉不全的早期临床和解剖结果,但据我们所知,比较这两种方法的长期临床和解剖结果的文献有限。我的目的是比较这些静脉内治疗方法的长期临床和解剖结果。方法选取248例18岁以上经静脉激光消融或氰基丙烯酸酯栓塞治疗大隐静脉功能不全的患者作为研究对象。已接受上述治疗方法以外治疗方法的患者未纳入本研究。根据所采用的治疗方法将相同数量的患者分为两组。本研究中各组的基线特征不完全匹配,年龄和术前反流持续时间值存在显著差异(p < 0.05),因此,使用调整了年龄和临床严重程度参数的模型(ANCOVA)对结果进行重新分析。结果共248例患者行静脉激光消融或氰基丙烯酸酯栓塞术,平均年龄51.22±13.20岁。两组患者平均年龄差异有统计学意义(p = 0.017)。研究患者术前CEAP评分平均值为3.07±0.57(2 ~ 6),术前VCSS评分平均值为6.85±1.18。研究患者的平均随访时间为3.5±0.50年,随访结束时,两组患者的CEAP分期和VCSS值均有所下降。结论静脉内氰基丙烯酸酯栓塞术与静脉内激光消融术具有相似的长期成功率,手术时间更短,术后恢复日常活动具有优势。这两种治疗方法,加上有效和可及的卫生保健系统,提供了多种治疗选择。本研究的结果表明,虽然这两种方法都可以长期减少CEAP阶段,但静脉内氰基丙烯酸酯栓塞可能提供更大的减少。然而,静脉内激光消融在减轻症状严重程度(VCSS)方面可能更有效,并且可能提供一种有效的治疗选择,并发症发生率较低,门诊疗效和成本效益相似。
{"title":"Comparison of long-term clinical and anatomical results of endovenous cyanoacrylate embolization and endovenous laser ablation methods in the treatment of great saphenous vein insufficiency.","authors":"Atilla Saraç","doi":"10.1177/17085381251379841","DOIUrl":"https://doi.org/10.1177/17085381251379841","url":null,"abstract":"<p><p>ObjectiveAlthough some publications are comparing the early clinical and anatomical results of endovenous laser ablation and endovenous cyanoacrylate embolization in great saphenous vein insufficiency, according to our knowledge, there are limited publications comparing the long-term clinical and anatomical results of these methods. I aimed to compare the long-term clinical and anatomical outcomes of these endovenous treatment methods.MethodsA total of 248 patients over the age of 18 who underwent endovenous laser ablation or endovenous cyanoacrylate embolization for the treatment of great saphenous vein insufficiency were included in the study. Patients who have been treated with a treatment method other than these methods were not included in this study. The equal numbers of patients were included in two groups according to the applied treatment methods. The groups were not fully matched in terms of baseline characteristics in this study, and significant differences were detected in age and preoperative reflux duration values (<i>p</i> < .05), and therefore, the results were re-analyzed with models (ANCOVA) adjusted for age and clinical severity parameters.ResultsEndovenous laser ablation or endovenous cyanoacrylate embolization procedures were performed in a total of 248 patients with a mean age of 51.22 ± 13.20 years. There was a statistically significant difference in mean age between the groups (<i>p</i> = .017). The mean preoperative CEAP score of study patients was 3.07 ± 0.57 (between 2 and 6), and the mean preoperative VCSS value was 6.85 ± 1.18. The average follow-up period of the study patients was 3.5 ± 0.50 years and at the end of the follow-up, a decrease in CEAP stage and VCSS values was observed in both groups.ConclusionsThe endovenous cyanoacrylate embolization offers similar long-term success rates to endovenous laser ablation, is a shorter procedure time, and offers advantages in returning to daily activities after the procedure. Both treatment methods, with effective and accessible healthcare systems, offer a variety of treatment options. The results of this study suggest that while both methods reduce the CEAP stage in the long term, endovenous cyanoacrylate embolization may provide a greater reduction. However, endovenous laser ablation may be more effective in reducing symptom severity (VCSS) and may offer an effective treatment option with lower complication rates and similar outpatient benefits and cost-effectiveness.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251379841"},"PeriodicalIF":0.9,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of balloon type and lesion location on outcomes following fistuloplasty. 球囊类型和病变位置对瘘管成形术后效果的影响。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-10-01 Epub Date: 2024-08-11 DOI: 10.1177/17085381241273126
Michael Parker, Philip C Bennett, Baljeet Dhillon, Ahmad Al-Thaher, Zahra Al-Alwani, Lee Elzubeir, Tugce Cetin, Maysoon Elkhawad, Tariq Ali

BackgroundThere is limited evidence supporting the optimal use of fistuloplasty to maintain vascular access at various lesion sites, despite its critical role in facilitating renal replacement therapy and the overall high failure rates of arteriovenous fistulas (AVFs). This study aims to identify covariates affecting primary and secondary patency following fistuloplasty of native upper limb vascular access AVFs.MethodsThis retrospective study included all patients who underwent fistuloplasty at a tertiary vascular centre over 4 years. Baseline characteristics were recorded, and factors associated with primary and secondary patency rates were analysed.ResultsA total of 206 patients (88 male, 118 female) with a mean age of 68 (±14) years underwent fistuloplasty during the study period. The prevalence of diabetes, ischaemic heart disease and antiplatelet usage were 33%, 21% and 70%, respectively. The median number of fistuloplasties per access during the follow-up period was 2 [1-3]. Fistulas were classified as radiocephalic (65), brachiocephalic (102) and brachiobasilic transposition (39). Recurrent stenosis (RS) was identified in 60 patients who had previous fistuloplasty before the study period, while 146 patients had de novo stenoses (DNS). Stenosis location significantly differed between RS and DNS (p = .03), with DNS primarily being anastomotic and RS predominantly in central and mixed locations. Younger fistulas were more likely to have anastomotic stenoses compared to those older than 1 year (p = .001). While no significant differences in primary patency (PP) were observed, secondary patency (SP) varied by stenosis location: Central 32 [13-42] months, Fistula vein 20 [12.5-35.5] months, Mixed 25 [13.5-37.5] months and Anastomotic 19 [7-29.5] months (p = .012).ConclusionStenosis location in AVFs is associated with the age and type of the fistula. Younger fistulas often fail due to anastomotic stenoses, which have lower secondary patency compared to stenoses at other sites. Preliminary data suggest that central stenoses, primarily occurring in older fistulas, exhibit better secondary patency following fistuloplasty than stenoses at other locations.

背景:尽管瘘成形术在促进肾脏替代疗法中发挥着关键作用,而且动静脉瘘(AVF)的总体失败率很高,但支持最佳使用瘘成形术来维持不同病变部位血管通路的证据却很有限。本研究旨在确定影响原发性上肢血管通路动静脉瘘瘘成形术后一次和二次通畅的协变量:这项回顾性研究纳入了四年来在一家三级血管中心接受瘘成形术的所有患者。记录了基线特征,并分析了与初次和二次通畅率相关的因素:研究期间共有206名患者(88名男性,118名女性)接受了瘘管成形术,平均年龄为68(±14)岁。糖尿病、缺血性心脏病和使用抗血小板药物的比例分别为 33%、21% 和 70%。在随访期间,每次通路瘘成形术的中位数为 2 [1-3]。瘘管分为放射脑型(65 例)、肱脑型(102 例)和肱二头肌转位型(39 例)。有 60 名患者在研究期间之前接受过瘘管成形术,而 146 名患者的瘘管为新狭窄(DNS)。RS和DNS的狭窄位置存在明显差异(p = .03),DNS主要位于吻合口,而RS主要位于中央和混合位置。与 1 年以上的瘘管相比,年轻的瘘管更容易出现吻合口狭窄(p = .001)。虽然初次通畅率(PP)没有明显差异,但二次通畅率(SP)因狭窄位置而异:中心静脉 32 [13-42] 个月、瘘管静脉 20 [12.5-35.5] 个月、混合静脉 25 [13.5-37.5] 个月和吻合静脉 19 [7-29.5] 个月(p = .012):结论:动静脉瘘的狭窄位置与瘘管的年龄和类型有关。较年轻的瘘管往往因吻合口狭窄而失败,与其他部位的狭窄相比,吻合口狭窄的二次通畅率较低。初步数据表明,主要发生在较年长瘘管中的中心狭窄在瘘管成形术后的二次通畅率要好于其他部位的狭窄。
{"title":"Influence of balloon type and lesion location on outcomes following fistuloplasty.","authors":"Michael Parker, Philip C Bennett, Baljeet Dhillon, Ahmad Al-Thaher, Zahra Al-Alwani, Lee Elzubeir, Tugce Cetin, Maysoon Elkhawad, Tariq Ali","doi":"10.1177/17085381241273126","DOIUrl":"10.1177/17085381241273126","url":null,"abstract":"<p><p>BackgroundThere is limited evidence supporting the optimal use of fistuloplasty to maintain vascular access at various lesion sites, despite its critical role in facilitating renal replacement therapy and the overall high failure rates of arteriovenous fistulas (AVFs). This study aims to identify covariates affecting primary and secondary patency following fistuloplasty of native upper limb vascular access AVFs.MethodsThis retrospective study included all patients who underwent fistuloplasty at a tertiary vascular centre over 4 years. Baseline characteristics were recorded, and factors associated with primary and secondary patency rates were analysed.ResultsA total of 206 patients (88 male, 118 female) with a mean age of 68 (±14) years underwent fistuloplasty during the study period. The prevalence of diabetes, ischaemic heart disease and antiplatelet usage were 33%, 21% and 70%, respectively. The median number of fistuloplasties per access during the follow-up period was 2 [1-3]. Fistulas were classified as radiocephalic (65), brachiocephalic (102) and brachiobasilic transposition (39). Recurrent stenosis (RS) was identified in 60 patients who had previous fistuloplasty before the study period, while 146 patients had de novo stenoses (DNS). Stenosis location significantly differed between RS and DNS (<i>p</i> = .03), with DNS primarily being anastomotic and RS predominantly in central and mixed locations. Younger fistulas were more likely to have anastomotic stenoses compared to those older than 1 year (<i>p</i> = .001). While no significant differences in primary patency (PP) were observed, secondary patency (SP) varied by stenosis location: Central 32 [13-42] months, Fistula vein 20 [12.5-35.5] months, Mixed 25 [13.5-37.5] months and Anastomotic 19 [7-29.5] months (<i>p</i> = .012).ConclusionStenosis location in AVFs is associated with the age and type of the fistula. Younger fistulas often fail due to anastomotic stenoses, which have lower secondary patency compared to stenoses at other sites. Preliminary data suggest that central stenoses, primarily occurring in older fistulas, exhibit better secondary patency following fistuloplasty than stenoses at other locations.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1215-1223"},"PeriodicalIF":0.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraluminal crossing of infrainguinal SFA chronic total occlusions may offer patency superiority compared to subintimal crossing. 腹股沟下SFA慢性全闭塞症的腔内穿刺与内膜下穿刺相比,可能具有更高的通畅性。
IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-10-01 Epub Date: 2024-08-16 DOI: 10.1177/17085381241273185
Maraya Camazine, Jack Coorts, Terrell Christian, Chase Schlesselman, Robin L Kruse, Jonathan Bath, Todd R Vogel

ObjectivesPatency for chronic total occlusions (CTO) of the superficial femoral artery (SFA) after endovascular interventions traditionally demonstrate a low 1-year patency ranging from 40%-60%. The optical coherence tomography (OCT) catheter (Avinger Inc., Redwood City, CA) uses light-based technology imaging to cross Trans-Atlantic Inter-Society Consensus D (TASC D) lesions intraluminally with direct intra-arterial visualization. Insufficient data exist evaluating intraluminal crossing with OCT imaging compared with traditional subintimal techniques. We evaluated outcomes for TASC D lesions crossed intraluminally.MethodsA retrospective analysis of patients with SFA TASC D lesions crossed intra-arterially with the OCT catheter imaging. Descriptive statistics evaluated patient characteristics which included patient demographics, Rutherford scores, ABIs, CTA information, lesion categorization, as well as runoff score. Patency at baseline, 30-day, 6-month, and 1-year outcomes were compared using t-tests. Cumulative patency rates were evaluated using Kaplan-Meier analysis.Results101 patients underwent elective intervention for SFA TASC D lesions with the OCT catheter. The crossing rate was 78.2%, mean lesion length was 16.2 cm, and runoff at the tibial level was 2.2 patent vessels. Mean age and BMI were 64 years and 29 kg/m2, respectively. Patient characteristics are male (57%); Caucasian (90%); ever smoking (85%); hypertension (82%), hyperlipidemia (70%), and diabetes (46%). Pre-operative computed tomography demonstrated SFA lesions were predominantly eccentric (91%) with mild to moderate calcification (90%). All underwent PTA, 87% were stented (mean stent length: 186.1 mm), mean crossing time was 13.4 min. Pre-operative, 30-day, 6-month, and 1-year post-operative mean Rutherford-Becker scores were 4, 1, 1, and 1, respectively (p < 0.0001). Mean pre-operative ABI was 0.49, compared to 0.84 at 30 days, 0.64 at 6 months, and 0.67 at 1 year (p < .0001). Duplex demonstrated 6- and 12-month primary patency of 89% and 75%; primary-assisted patency was 94% and 84%.ConclusionsThe OCT imaging catheter successfully crossed long chronic total occlusions of the SFA using direct intra-arterial imaging. Compared to subintimal techniques, patients had high 1-year primary patency and prolonged symptom improvement with intraluminal crossing. These data suggest that intraluminal crossing of TASC D lesions may be superior to traditional subintimal crossing techniques.

目的:传统上,股浅动脉(SFA)慢性全闭塞(CTO)经血管内介入治疗后的1年通畅率较低,仅为40%-60%。光学相干断层扫描(OCT)导管(Avinger Inc.,加利福尼亚州红木城)采用光成像技术,通过动脉内直视,在腔内穿越跨大西洋学会间共识 D(TASC D)病变。与传统的内膜下技术相比,用 OCT 成像评估腔内穿刺的数据不足。我们对腔内穿刺 TASC D 病变的疗效进行了评估:对使用 OCT 导管成像进行动脉内穿刺的 SFA TASC D 病变患者进行回顾性分析。描述性统计评估了患者特征,包括患者人口统计学特征、卢瑟福评分、ABI、CTA信息、病变分类以及径流评分。使用 t 检验比较基线、30 天、6 个月和 1 年的通畅率。采用 Kaplan-Meier 分析法评估累积通畅率:101名患者使用OCT导管对SFA TASC D病变进行了选择性介入治疗。穿越率为 78.2%,平均病变长度为 16.2 厘米,胫骨水平的径流为 2.2 条通畅血管。平均年龄和体重指数分别为 64 岁和 29 kg/m2。患者特征为男性(57%)、白种人(90%)、吸烟(85%)、高血压(82%)、高脂血症(70%)和糖尿病(46%)。术前计算机断层扫描显示,SFA病变以偏心为主(91%),伴有轻度至中度钙化(90%)。所有患者均接受了PTA手术,87%的患者接受了支架植入(平均支架长度:186.1毫米),平均穿越时间为13.4分钟。术前、术后30天、6个月和1年的平均Rutherford-Becker评分分别为4、1、1和1(P < 0.0001)。术前平均 ABI 为 0.49,而术后 30 天为 0.84,6 个月为 0.64,1 年为 0.67(P < 0.0001)。双光谱显示,6个月和12个月的原发性通畅率分别为89%和75%;原发性辅助通畅率分别为94%和84%:结论:通过直接动脉内成像,OCT 成像导管成功地穿过了 SFA 长距离慢性全闭塞。与内膜下技术相比,患者的 1 年初次通畅率较高,而且腔内贯通后症状改善时间较长。这些数据表明,腔内穿越 TASC D 病变可能优于传统的内膜下穿越技术。
{"title":"Intraluminal crossing of infrainguinal SFA chronic total occlusions may offer patency superiority compared to subintimal crossing.","authors":"Maraya Camazine, Jack Coorts, Terrell Christian, Chase Schlesselman, Robin L Kruse, Jonathan Bath, Todd R Vogel","doi":"10.1177/17085381241273185","DOIUrl":"10.1177/17085381241273185","url":null,"abstract":"<p><p>ObjectivesPatency for chronic total occlusions (CTO) of the superficial femoral artery (SFA) after endovascular interventions traditionally demonstrate a low 1-year patency ranging from 40%-60%. The optical coherence tomography (OCT) catheter (Avinger Inc., Redwood City, CA) uses light-based technology imaging to cross Trans-Atlantic Inter-Society Consensus D (TASC D) lesions intraluminally with direct intra-arterial visualization. Insufficient data exist evaluating intraluminal crossing with OCT imaging compared with traditional subintimal techniques. We evaluated outcomes for TASC D lesions crossed intraluminally.MethodsA retrospective analysis of patients with SFA TASC D lesions crossed intra-arterially with the OCT catheter imaging. Descriptive statistics evaluated patient characteristics which included patient demographics, Rutherford scores, ABIs, CTA information, lesion categorization, as well as runoff score. Patency at baseline, 30-day, 6-month, and 1-year outcomes were compared using t-tests. Cumulative patency rates were evaluated using Kaplan-Meier analysis.Results101 patients underwent elective intervention for SFA TASC D lesions with the OCT catheter. The crossing rate was 78.2%, mean lesion length was 16.2 cm, and runoff at the tibial level was 2.2 patent vessels. Mean age and BMI were 64 years and 29 kg/m<sup>2</sup>, respectively. Patient characteristics are male (57%); Caucasian (90%); ever smoking (85%); hypertension (82%), hyperlipidemia (70%), and diabetes (46%). Pre-operative computed tomography demonstrated SFA lesions were predominantly eccentric (91%) with mild to moderate calcification (90%). All underwent PTA, 87% were stented (mean stent length: 186.1 mm), mean crossing time was 13.4 min. Pre-operative, 30-day, 6-month, and 1-year post-operative mean Rutherford-Becker scores were 4, 1, 1, and 1, respectively (<i>p</i> < 0.0001). Mean pre-operative ABI was 0.49, compared to 0.84 at 30 days, 0.64 at 6 months, and 0.67 at 1 year (<i>p</i> < .0001). Duplex demonstrated 6- and 12-month primary patency of 89% and 75%; primary-assisted patency was 94% and 84%.ConclusionsThe OCT imaging catheter successfully crossed long chronic total occlusions of the SFA using direct intra-arterial imaging. Compared to subintimal techniques, patients had high 1-year primary patency and prolonged symptom improvement with intraluminal crossing. These data suggest that intraluminal crossing of TASC D lesions may be superior to traditional subintimal crossing techniques.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1102-1107"},"PeriodicalIF":0.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141992489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1